Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal masses.
biopsy
communication
kidney neoplasms
small renal masses
uncertainty
Journal
BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721
Informations de publication
Date de publication:
23 Jul 2024
23 Jul 2024
Historique:
medline:
23
7
2024
pubmed:
23
7
2024
entrez:
23
7
2024
Statut:
aheadofprint
Résumé
To understand the facilitators and barriers to the implementation of renal tumour biopsy (RTB) in the diagnostic pathway for renal tumours in England. Participants consisted of patients who had a renal tumour diagnosed and/or treated at one of five tertiary centres in England, healthcare professionals involved in the direct care of patients diagnosed with renal tumours, and clinical service managers and commissioners. The study employed a mixed-methods research methodology consisting of individual interviews and an on-line survey that explored the types of facilitators and barriers individuals perceived and experienced and the frequency in which these were reported. A public dissemination event took place following the completion of data collection; to facilitate discussion of potential solutions to implementing RTB. There were 50 participant interviews (23 patients, 22 clinicians, and five health service commissioners/operations managers). The patient on-line survey received 52 responses, and the clinician survey received 22 responses. Patients most frequently reported influences in choosing whether to undergo RTB pertained to wanting to know the diagnosis of their kidney mass (40%), the advice or information provided by healthcare professionals (40%), and not wishing to delay treatment (23%). Clinicians most frequently reported barriers to recommending RTB related to their uncertainty of diagnostic accuracy (56%), availability of appointments or hospital beds (52%), concerns of risk of bleeding (44%), risk of seeding (41%), and delays in meeting national cancer pathway targets (41%). The dissemination event was attended by 18 participants (seven patients and 11 clinicians). Suggestions to improve implementation included reducing variation and promotion of standardisation of practice by a consensus statement, increasing the evidence base (clinicians) and improved communication by developing better patient aids such as videos and diagrams (patients and clinicians). Implementation of RTB may be dependent on the quality of information provided, its format and perceived reliability of the information. Increased utilisation of RTB may be improved by development of a consensus statement on the role of biopsy, with patients expressing a preference for alternative information aids such as patient videos.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
Références
Welch HG, Skinner JS, Schroeck FR, Zhou W, Black WC. Regional variation of computed tomographic imaging in the United States and the risk of nephrectomy. JAMA Intern Med 2018; 178: 221–227
Neves JB, Tran MGB. Uncoupling diagnosis and treatment of incidentally imaged renal masses. JAMA Intern Med 2018; 178: 728
Warren H, Tran MGB. Incidental small renal tumours: are we performing unnecessary surgery? Trends Urol Men's Health 2023; 14: 11–14
Cancer Research UK. Kidney Cancer Statistics. Cancer Research UK, 2024. Available at: https://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/kidney‐cancer#heading‐Four. Accessed 23rd May 2024
Tang Y, Liu F, Mao X, et al. The impact of tumor size on the survival of patients with small renal masses: a population‐based study. Cancer Med 2022; 11: 2377–2385
Fernando A, Fowler S, O'Brien T, British Association of Urological S. Nephron‐sparing surgery across a nation – outcomes from the British Association of Urological Surgeons 2012 national partial nephrectomy audit. BJU Int 2016; 117: 874–882
Ljungberg B, Albiges L, Abu‐Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol 2019; 75: 799–810
Patel DN, Ghali F, Meagher MF, et al. Utilization of renal mass biopsy in patients with localized renal cell carcinoma: a population‐based study utilizing the National Cancer Database. Urol Oncol 2021; 39: 79.e1–8
Marconi L, Dabestani S, Lam TB, et al. Systematic review and meta‐analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 2016; 69: 660–673
Patel HD, Johnson MH, Pierorazio PM, et al. Diagnostic accuracy and risks of biopsy in the diagnosis of a renal mass suspicious for localized renal cell carcinoma: systematic review of the literature. J Urol 2016; 195: 1340–1347
Richard PO, Lavallée LT, Pouliot F, et al. Is routine renal tumor biopsy associated with lower rates of benign histology following nephrectomy for small renal masses? J Urol 2018; 200: 731–736
Warren H, Neves JB, Tran MGB. Renal oncocytoma: landscape of diagnosis and management. BJU Int 2021; 128: 685–687
Neves JB, Withington J, Fowler S, et al. Contemporary surgical management of renal oncocytoma: a nation's outcome. BJU Int 2018; 121: 893–899
Ljungberg B, Bex A, Albiges L, et al. EAU Guidelines on Renal Cell Carcinoma. Arnhem: European Association of Urology, 2024
Kim JH, Li S, Khandwala Y, Chung KJ, Park HK, Chung BI. Association of prevalence of benign pathologic findings after partial nephrectomy with preoperative imaging patterns in the United States from 2007 to 2014. JAMA Surg 2019; 154: 225–231
Patel RM, Safiullah S, Okhunov Z, et al. Pretreatment diagnosis of the small renal mass: status of renal biopsy in the United States of America. J Endourol 2018; 32: 884–890
Richard PO, Martin L, Lavallee LT, et al. Identifying the use and barriers to the adoption of renal tumour biopsy in the management of small renal masses. Can Urol Assoc J 2018; 12: 260–266
Warren H, Rautio A, Marandino L, et al. Diagnostic biopsy for small renal tumours: a survey of current European practice. Eur Urol Open Sci 2024; 62: 54–60
QSR International. NVivo [Program]. Melbourne, Vic.: QSR International, 2018
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3: 77–101
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019; 95: 103208
SPSS Inc. SPSS. Chicago, IL: IBM, 2020
Cancer Research UK. Kidney Cancer Incidence Statistics. Cancer Research UK, 2024. Available at: https://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/kidney‐cancer/incidence#heading‐Zero. Accessed 23rd May 2024
Tanabalan CNJ, Walkden M, Grant L, et al. MP36‐07 routine mass biopsy in diagnosis of renal cancer. J Urol 2018; 188: e459
World Health Organisation (WHO). WHO Classification of Tumours; Urinary and Male Genital Tumours, 5th edn. Lyon: International Agency for Research on Cancer, 2022
Baboudjian M, Moser D, Yanagisawa T, et al. Benefit and harm of active surveillance for biopsy‐proven renal oncocytoma: a systematic review and pooled analysis. Eur Urol Open Sci 2022; 41: 8–15
Richard PO, Jewett MA, Bhatt JR, Evans AJ, Timilsina N, Finelli A. Active surveillance for renal neoplasms with oncocytic features is safe. J Urol 2016; 195: 581–586
Hart TL, Blacker S, Panjwani A, Torbit L, Evans M. Development of multimedia informational tools for breast cancer patients with low levels of health literacy. Patient Educ Couns 2015; 98: 370–377
Burruni R, Lhermitte B, Cerantola Y, et al. The role of renal biopsy in small renal masses. Can Urol Assoc J 2016; 10: E28–E33
NHS England, The British Association of Urological Surgeons, British Association of Urological Nurses. Urology: towards better care for patients with kidney cancer. 2023